ACTRN12620000056998
Not yet recruiting
未知
A multi-centre, multi-specialty collaboration for creating a consistent valid scoring tool using patient skin field photographs for tumour severity and extent assessment of skin field cancerisation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Skin Cancer including Keratinocyte Carcinomas
- Sponsor
- GenesisCare
- Enrollment
- 150
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Treatable region of Skin Field Cancerisation in at least one of the following regional areas:
- •o Cheek (one)
- •o Ear (one)
- •o Forearm (one)
- •o Back of Hand (one)
- •o Lower leg (one)
- •o Top of foot (one)
- •o Chest (Decolletage)
- •o Torso (or front or back)
- •2\. De\-identified \- Photographs of participants over 18 years of age. Photographs will be collected only from two sites from patients who attended clinics .These two sites are QIDerm in Brisbane and St Vincent's Hospital in Melbourne.
Exclusion Criteria
- •Poor quality photographs;
- •Other dermatoses effecting assessment (e.g. inflammatory
- •skin diseases) that may confuse scorers.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2022-001837-35-LTBasilea Pharmaceutica International Ltd, Allschwil15
Active, not recruiting
Phase 1
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2022-001837-35-PLBasilea Pharmaceutica International Ltd, Allschwil15
Active, not recruiting
Phase 1
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2022-001837-35-SKBasilea Pharmaceutica International Ltd, Allschwil8
Active, not recruiting
Phase 1
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageEUCTR2022-001837-35-DEBasilea Pharmaceutica International Ltd, Allschwil8
Active, not recruiting
Phase 1
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageEUCTR2022-001837-35-BGBasilea Pharmaceutica International Ltd, Allschwil8